logo
Significant change for how NHS will be managed locally amid 50 per cent cuts

Significant change for how NHS will be managed locally amid 50 per cent cuts

Yahoo17-05-2025

Decisions on health care could be made by a new care board spanning from Christchurch in the east to Exmoor in the west, and encompassing Bath, Wiltshire and Swindon, could all be made by one body.
Integrated Care Boards make commissioning and spending decisions on health care for differing areas across England including hospitals, GPs' surgeries and pharmacies
Decisions made in Swindon and Wiltshire are made by the Bath & North East Somerset, Swindon and Wiltshire ICB.
But they have all been instructed to make 50 per cent cost savings after reforms to the NHS in England were announced by the government earlier this year.
Damning report finds serious safety and quality failings in council housing
Amazon asks to make big changes to its lorries at Swindon warehouse
The Local Democracy Reporter understands that a briefing to regional NHS staff said that initially the BSW ICB would 'cluster' with the boards for Somerset and Dorset to create a much larger area.
The plans must be submitted to NHS England by the end of the month before being forwarded to Whitehall for a final decision.
The briefing added: 'Once given the go-ahead, reshaped ICBs are expected to come together under 'clustering' arrangement from later this year with a view to formal merger from either April 2026 or April 2027.'
READ MORE:
Other regional clusters might be Gloucestershire ICB joining with the Bristol, North Somerset & South Gloucestershire Board, while the boards for Cornwall & the Scilly Isles and Devon are also expected to cluster together.
A spokesperson for the Bath & North East Somerset, Swindon and Wiltshire ICB said: 'All ICBs in England are being asked to significantly reduce running costs and shift to a more strategic role, with different responsibilities for us and other parts of our health and care system.
'This is part of the wider nationally-driven NHS reform programme to reduce management costs and focus more money on the front line.
'BSW ICB is exploring plans to cluster with Somerset and Dorset ICBs. This proposal is still at an early stage and no decisions have been made.'
Both Dorset and Somerset ICBs were contacted for comment. A spokesperson for the Dorset board said it was unable to comment, and the Somerset ICB has not responded to that request.
The BSW ICB has only been in existence since 2022. Before that, commissioning decisions were made by Care Commissioning Groups, which operated separately in each area.
They were working together for nearly two years before voting to merge to form an ICB in 2019.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

KKR Raises Offer for Assura, Valuing Landlord at £1.7 Billion
KKR Raises Offer for Assura, Valuing Landlord at £1.7 Billion

Bloomberg

time31 minutes ago

  • Bloomberg

KKR Raises Offer for Assura, Valuing Landlord at £1.7 Billion

A consortium led by KKR & Co has increased its bid in a takeover battle for Assura Plc, valuing the UK healthcare landlord at £1.7 billion ($2.3 billion). KKR and its co-bidder, Stonepeak Partners LP, sweetened their cash offer to an implied total value of 52.1 pence for each Assura share, inclusive of declared dividends, according to a statement on Wednesday. That compares with an implied total value of 51.7 pence put forward by rival Primary Health Properties Plc earlier.

ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights
ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights

Yahoo

time2 hours ago

  • Yahoo

ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights

EINDHOVEN, the Netherlands, June 11, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function and independence in people with spinal cord injury and other movement disabilities, today announces that it will host a webcast to discuss its Q1 2025 business update and year-to-date highlights. The webcast will be held on June 17, 2025, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver. To join the session, please register using this link. About ONWARD Medical ONWARD Medical is the leading neurotechnology company pioneering therapies to restore movement, function and independence in people with spinal cord injury (SCI) and other movement disabilities. Building on more than a decade of scientific discovery, preclinical research, and clinical studies conducted at leading hospitals, rehabilitation clinics, and neuroscience laboratories, the Company has developed ARC Therapy, which has been awarded ten Breakthrough Device Designations from the US Food and Drug Administration (FDA). The Company's ARC-EX® System is cleared for commercial sale in the US. In addition, the Company is developing an investigational implantable system called ARC-IM® with and without an implanted brain-computer interface (BCI). Headquartered in the Netherlands, the Company has a Science and Engineering Center in Switzerland and a US office in Boston, Massachusetts. The Company is listed on Euronext Paris, Brussels, and Amsterdam (ticker: ONWD) and its US ADRs can be traded on OTCQX (ticker: ONWRY). To learn more about ONWARD Medical's commitment to partnering with the spinal cord injury community to develop innovative solutions for restoring movement, function, and independence after spinal cord injury, please visit To be kept informed about the Company's technologies, research studies, and the availability of therapies in your area, please complete this webform. For Media Inquiries: Sébastien Cros, VP Communications media@ For Investor Inquiries: investors@ Disclaimer Certain statements, beliefs, and opinions in this press release are forward-looking, which reflect the Company's or, as appropriate, the Company directors' current expectations and projections about future events. By their nature, forward-looking statements involve several risks, uncertainties, and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, delays in regulatory approvals, changes in demand, competition, and technology, can cause actual events, performance, or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions, or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release. Trademarks: ONWARD, ARC-EX, ARC-IM, ARC-BCI, and the stylized O-Logo are proprietary and registered trademarks of ONWARD Medical. Unauthorized use is strictly prohibited. ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive). Other Investigational Products: All other ONWARD Medical devices and therapies including ARC-IM and ARC-BCI are investigational and not available for commercial use.

Take a look at the finalists for the Pride of Cumbria NHS Worker of the Year award
Take a look at the finalists for the Pride of Cumbria NHS Worker of the Year award

Yahoo

time3 hours ago

  • Yahoo

Take a look at the finalists for the Pride of Cumbria NHS Worker of the Year award

The Pride of Cumbria Awards 2025 NHS Worker of the Year recognises heroes from the NHS who have gone above and beyond. The award, which is sponsored by NRL, is set to highlight those who 'show bravery, courage and resilience in their day-to-day work, demonstrated by outstanding acts of kindness and compassion to families and patients'. The Pride of Cumbria Awards 2025 will be held on Wednesday, June 18 at the Greenhill Hotel, Wigton. Sylvie Booth Sylvie Booth (Image: Supplied) Orthoptist Sylvie works within the North Cumbria Integrated Care Trust, going 'above and beyond under very challenging working conditions'. Her nominator said: "The gift of sight through the services Sylvie provides, gives those with sight impairment or changes in sight following events like stroke, is life changing in terms of individual safety, sense of self worth, ability to access rehab (e.g. learning to read or walk again), returning to work and living a quality and meaningful life. "Sylvie very much deserves to be recognised for this." Laura Street Laura Street (Image: Supplied) Laura works as the improvement lead for cancer at the North Cumbria Integrated Care Trust, and is said to have an 'unwavering dedication' to her role. Her nominator said: "Laura has been fundamental to some massive improvements in Cancer care at North Cumbria this year, and she is exceptionally dedicated to ensuring that every patient gets timely, efficient and compassionate care on their cancer journey. "Laura shows tremendous resilience, courage and compassion to patients and their families, and is unwaveringly dedicate to ensuring that the local population has access to the best cancer care possible." Valerie Coltart Valerie Coltart (Image: Supplied) Valerie works as an NHS dietician at the Cumberland Infirmary being nominated by the parent of one of her patients for 'always going the extra mile' in her work. Her nominator said: "Valerie comes for home visits when my child is having a bad day so he doesn't miss an appointment, she also organises if there is a slip up with his feeds and medication and she will bring things to us if needed on her way home from collecting her own children, she is the nicest person too, and deserves to be recognised."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store